HTX-011
HTX-011 is a pharmaceutical drug with 17 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
9
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.8%
15 of 16 finished
6.3%
1 ended early
0
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
HTX-011 for Post-bunionectomy Analgesia
Study of Post-Herniorrhaphy Non-opioid MMA Regimens
Pediatric Postoperative Analgesia Herniorrhaphy Study
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Phase 2 Bunionectomy HTX-011 Administration Study
Clinical Trials (17)
HTX-011 for Post-bunionectomy Analgesia
Study of Post-Herniorrhaphy Non-opioid MMA Regimens
Pediatric Postoperative Analgesia Herniorrhaphy Study
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Phase 2 Bunionectomy HTX-011 Administration Study
Phase 2B Upper Extremity Nerve Block Study
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
Pilot Herniorrhaphy Study for Postoperative Analgesia
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Phase 2 Herniorrhaphy Study for Opioid Elimination
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
HTX-011 in Spinal Surgery
HTX-011 Administration Study in Planned Caesarean Section Procedure
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17